References
- Liu CY, Wang CH, Chen TC, et al. Increased levels of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer. Br J Cancer 1998; 78: 534–41.
- Slutsky AS, Drazen JM, Silkoff PE, et al. Recommendations for standardized procedures for the online and offline measure-ment of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. Am J Respir Crit Care Med 1999; 160: 2104–17.
- Hogman M, Drca N, Ehrstedt C, Merildinen P. Exhaled nitric oxide partitioned into alveolar, lower airways and nasal contributions. Respir Med 2000; 94: 985–91.
- Diehl V, Franklin J, Hasenclever D, et al. BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's lymphoma study group. J Clin Oncol 1998; 16: 3810–21.
- Kharitonov SA, Gonio F, Kelly C, et al. Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur Respir J 2003; 21: 433–8.
- Hogman M, Anderson SD, Hakansson L, et al. Inhaled mannitol shifts exhaled nitric oxide in opposite directions in asthmatics and healthy subjects. Respir Physiol 2001; 124: 141–50.
- Gow AJ, Luchsinger BP, Pawloski JR, et al. The oxyhemoglo-bin reaction of nitric oxide. Proc Natl Acad Sci USA 1999; 96: 9027–32.
- Thomsen LL, Miles DW. Role of nitric oxide in tumour progression: lessons from human tumours. Cancer Metastasis Rev 1998; 17: 107–18.
- Lala PK, Orucevic A. Role of nitric oxide tumor progression: lessons from experimental tumors. Cancer Metastasis Rev 1998; 17: 91–106.
- Hogman M, Holmkvist T, Wegener T, et al. Extended NO analysis applied to patients with COPD, allergic asthma and allergic rhinitis. Respir Med 2002; 96: 24–30.
- Silkoff PE, Sylvester JT, Zamel N, Permutt S. Airway nitric oxide diffusion in asthma. Role in pulmonary function and bronchial responsiveness. Am J Respir Crit Care Med 2000; 161: 1218–28.